gamma-Interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation

S Bose1, P Brooks, G G Mason

  • 1Department of Biochemistry, University of Bristol, School of Medical Sciences, Bristol BS8 1TD, U.K.

The Biochemical Journal
|January 5, 2001
PubMed

Insights

Gamma interferon (IFN) treatment alters proteasome composition in mammalian cells. It increases PA28-proteasome complexes while decreasing 26S proteasomes and reducing subunit phosphorylation.

Area of Science:

  • Cellular biology
  • Molecular mechanisms of protein degradation

Background:

  • Proteasomes are crucial for intracellular protein degradation, existing as 26S proteasomes (ATP-dependent) and PA28-proteasome complexes.
  • PA28 complexes are upregulated by gamma interferon (IFN), along with certain proteasome subunits, suggesting a role in IFN-mediated cellular responses.

Purpose of the Study:

  • To investigate the impact of gamma-IFN on the composition of proteasome complexes.
  • To examine the effect of gamma-IFN on the phosphorylation status of proteasome subunits.

Main Methods:

  • Mammalian cells were treated with gamma-interferon (IFN).
  • Proteasome complex levels and subunit phosphorylation were analyzed using biochemical assays.

Main Results:

  • Gamma-IFN treatment led to a decrease in 26S proteasomes and a corresponding increase in PA28-proteasome complexes.
  • No free 19S regulatory complexes were detected post-treatment.
  • Gamma-IFN-inducible subunits LMP2 and LMP7 were found in both PA28-proteasome and 26S proteasome complexes.
  • Phosphorylation of proteasome subunits, including C8 alpha and C9, significantly decreased after gamma-IFN treatment.

Conclusions:

  • Gamma-IFN influences the dynamic assembly of proteasome regulatory complexes.
  • Proteasome subunit phosphorylation, particularly of alpha subunits, may serve as a regulatory mechanism controlling proteasome function and composition.

Related Concept Videos

The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...